MENU CLOSE
About Us

Who We Are

Our Social Responsibility

Events

Exhibitions

Activeties

Members

Hospitals

Individuals

Companies

Member Benefits

 
Bio-medical projectsi

State Key Laboratory of Biotherapy

Cooperation

Achievement Exhibition

Scimea Journals

Signal Transduction and Targeted Therapy

News

News Information

 
Home   >  News
04 Mar 2020
363
Interview | Nobuyuki Watanabe: More Cooperation Desired between Southwest China and Japan
SCIMEA




Source: BOPUZHIKU


© SCIMEA and Bopu Zhiku

 


Video


(Click here for more info)

 

图片1.png 


Nobuyuki Watanabe, Consul General of Japan in Chongqing

 


The 2019 China-Japan Advanced Medical and New Drug R&D Summit and Achievements Transformation Conference was held on November 10, with an aim to promote the sharing of medical and new drug R&D and innovation achievements between Japan and China, and to build an international up-scale promotion platform of the pharmaceutical industry.  

 


At the star-studded event, we interviewed Nobuyuki Watanabe, Consul General of Japan in Chongqing.

 


Born in Shizuoka Prefecture, Mr. Watanabe graduated from Shizuoka University with a law degree, and started to work in the Ministry of Foreign Affairs (MOFA) of Japan since 1983.

 


During the following 20 years, he joined a Chinese-learning program in Nankai University in Tianjin, China, and worked in the Embassy of Japan in China and the department of MOFA that deals with China-related affairs.

 


Having spent 10 years working in the Embassy of Japan in China, Mr. Watanabe is well-versed in Chinese culture. Setting foot on China for the first time in 17 years, Mr. Watanabe talked with the media outlets at the event, including Bopu Zhiku, in great delight.  

图片2.png 


When asked about how to effectively promote cooperation between Japan and southwest China, he said that compared with China’s coastal areas, the Southwest region crossed paths with Japan less frequently. However, its remarkable economic soar, an acreage three times that of Japan, and close ties with Central Asia and Europe promise a prosperous future.   


Confident in the strengths of southwest China, he would like to see more cooperation and exchange between the region and Japan on the fronts of economy, culture and medicine.

 


Bopu Zhiku went on and asked Mr. Watanabe about the biggest strength of the pharmaceutical industry in southwest China, and the initiatives the region should adopt to work with Japan’s pharmaceutical industry and advance economic cooperation between the two countries. Humbling himself as an outsider of the medical realm, he dubbed Chengdu as the kernel of development in the Southwest and a matured hotbed for advanced medical industry. He had faith in the city’s promising prospects and hoped to see more exchange and a closer tie between Chengdu and Japan.


After returning to China as the Consul General of Japan in Chongqing, Mr. Watanabe was mostly impressed by the drastic change in Chinese people's lifestyles. He lauded that the positive attitude of the modern Chinese towards life and work was as inspiring as the country's soaring economy.

图片3.png 


(Nobuyuki Watanabe, Consul General of Japan in Chongqing, is being interviewed)



With Mr. Watanabe’s unwavering confidence in a deeper exchange between Japan and China, the interview ended on a delightful note.  

 


China’s vigorous growth and remarkable scientific achievements have laid the cornerstone for the 2019 China-Japan Advanced Medical and New Drug R&D Summit and Achievements Transformation Conference.

 


With all hands on deck, the conference will help shape Chengdu into a world-class pole of medicine and healthcare, and create a nurturing climate for bio-medical innovation up to the international standard. It is believed that Japan and China would initiate deeper exchange in advanced medicine and R&D of new drugs.

 


Special thanks to the conference organizer for making the interview with Mr. Nobuyuki Watanabe possible.


All rights reserved.

 

 

 

 


Professor Kang Yan Shares the "Black Technology" for Critical Consultation in 5G Era
2019 Western China (Meishan) International Medical Exchange and Investment Summit & International Thyroid & Parathyroid Medicine Conference Successfully Held
Let the world hear WCH- the collection of 10 researches from the Department of Urology, West China Hospital, Sichuan University in 2019 ASCO-GU Cancer Symposium
The "2019 Chinese Medicinal Chemistry Symposium" with Nearly 4,000 Participants Successfully Concluded with Experts Comments as Follow...
Academician Weihong Song from Canada Publishes an Article on MedComm: Challenges of COVID-19 Pandemic: Strategies and Methods for the Elderly and Alzheimer Patients
Latest Events Journals News Members About Us Home
Contact Us

Address: No. 1103-1105, Building 6, S2, Global Center, High-tech Zone, Chengdu

Email: scimea@163.com 

Tel: (0086-)028-63859818   

Fax: (0086-)028-63859818   

Contact: (0086-)19113901604 (wechat:19113901604)


Follow Us
Copyright © 2009-2019 SCIMEA. All rights reserved 蜀ICP备19011649号-1